--- a
+++ b/clusters/9knumclustersv2/clust_1563.txt
@@ -0,0 +1,49 @@
+Severe liver dysfunction (Child-Pugh Class B or C) is not present; and
+Child-Pugh class A
+Patients with liver disease classified as Child Pugh class A or B, with score =< 
+Chronic liver disease, Child-Pugh class B or C
+Impaired liver function Child-Pugh class B or C (score -).
+Child-Pugh class B and C liver failure
+Obtained with  days of registration: Child Pugh class A (- points) or B ( points)
+Child Pugh class B (,) and class C are excluded.
+Child-Pugh class-A liver function
+Child-Pugh class A or B liver function
+Obtained =<  days prior to registration: If baseline liver disease, Child Pugh score not exceeding class A
+Child Pugh class B or greater hepatic dysfunction
+Child Pugh class B & C
+Several hepatic impairments, define as Child-Pugh Class C or worse
+Child-Pugh class A or B without ascites
+Child Pugh class C hepatic dysfunction
+Child-Pugh Class A without either current encephalopathy or ascites.
+Child-Pugh Class A
+Cirrhotic status of Child-Pugh class A or B
+Liver function status Child-Pugh (CP) Class A. CP status should be calculated based on clinical findings and laboratory results during the screening period.
+Liver disease with Child-Pugh class B or C liver dysfunction
+HCC patients only: Child Pugh class A or B liver disease
+Subject is classified into Child-Pugh class C
+Has a Child-Pugh Class A liver score within  days of first dose of study drug.
+Subject is classified into Child-Pugh class C
+Child-Pugh Class A
+Patients with hepatocellular carcinoma may be eligible provided they have total bilirubin ? . x ULN and are considered Child-Pugh Class A or Child-Pugh Class B (Child-Pugh Class B with a total Child-Pugh score not to exceed ).
+Has a Child-Pugh Class A liver score within  days of first dose of study drug
+Preserved liver function (Child-Pugh class A or B)
+Subject has hepatic function status of Child Pugh Class A at Screening.
+Subject has status of Child-Pugh Class B or C at Screening.
+Child-Pugh class A
+Child-Pugh liver function class A
+Systemic disease that would prevent study treatment (uncontrolled hypertension, cardiovascular renal, hepatic (including Child-Pugh Class B and C) or metabolic disease)
+Child-Pugh Class A or B.
+Subject has Child-Pugh score of less than  (ie, class A or better) with neither encephalopathy nor clinically significant ascites (ascites requiring paracentesis within  months of signing the ICF is excluded). Child-Pugh status is calculated based on clinical findings and laboratory results during the screening period.
+Child Pugh Class A disease
+Child-Pugh class A with no clinically apparent ascites
+Child-Pugh class of A
+Child-Pugh Class B and C.
+Patients with impaired hepatic function as defined by Childs-Pugh class B or C
+Child Pugh Class A liver function score
+Must be Child-Pugh class A a. Patients with uncontrolled massive ascites or presence of hepatic encephalopathy are excluded
+Child Pugh class A or B liver disease
+Child-Pugh Class A.
+Child-Pugh Class A in the absence of hepatoencephalopathy or clinically evident ascites
+Child Pugh class A liver function or class B
+Child-Pugh class B and C liver failure
+Child-Pugh liver function Class B or C.